Skip to main content
. 2022 Mar 15;24(3):299–306. doi: 10.1038/s41556-022-00852-9

Extended Data Fig. 5. mTOG expression is independent from recurrent mutations and cytogenetic abnormalities in MDS.

Extended Data Fig. 5

Mutational landscape of the MDS patient cohort (n=50) used for this study. Patients are stratified based on mTOG levels from low to high. mTOG levels were independent from recurrent MDS genetic abnormalities (Mann-Whitney U test).

Source data